Primary |
Hypertension |
79.7% |
Blood Pressure |
5.1% |
Blood Cholesterol Abnormal |
2.5% |
Depression |
2.5% |
Arthritis |
1.3% |
Blood Pressure Abnormal |
1.3% |
Gout |
1.3% |
Headache |
1.3% |
Hormone Replacement Therapy |
1.3% |
Incontinence |
1.3% |
Oedema |
1.3% |
Secondary Hypertension |
1.3% |
|
Cerebrovascular Accident |
19.8% |
Renal Failure |
14.3% |
Renal Disorder |
8.8% |
Blood Pressure Increased |
6.6% |
Hypertension |
5.5% |
Dizziness |
4.4% |
Hypotension |
4.4% |
Type 1 Diabetes Mellitus |
4.4% |
Weight Decreased |
4.4% |
Cough |
3.3% |
Depression |
3.3% |
Drug Ineffective |
3.3% |
Accidental Drug Intake By Child |
2.2% |
Angioedema |
2.2% |
Blood Creatine Phosphokinase Increased |
2.2% |
Blood Sodium Decreased |
2.2% |
Diarrhoea |
2.2% |
Feeling Abnormal |
2.2% |
Humerus Fracture |
2.2% |
Hyperkalaemia |
2.2% |
|
Secondary |
Hypertension |
68.0% |
Blood Pressure Abnormal |
12.0% |
Intervertebral Disc Disorder |
8.0% |
Diabetic Neuropathy |
4.0% |
Oedema |
4.0% |
Prophylaxis Against Gastrointestinal Ulcer |
4.0% |
|
Loss Of Consciousness |
10.3% |
Pruritus |
10.3% |
Dizziness |
6.9% |
Hyperkalaemia |
6.9% |
Hypertension |
6.9% |
Oedema Peripheral |
6.9% |
Weight Decreased |
6.9% |
Arthritis |
3.4% |
Blood Creatine Increased |
3.4% |
Blood Pressure Decreased |
3.4% |
Blood Pressure Inadequately Controlled |
3.4% |
Blood Pressure Increased |
3.4% |
Dehydration |
3.4% |
Drug Ineffective |
3.4% |
Drug Interaction |
3.4% |
Flank Pain |
3.4% |
Limb Discomfort |
3.4% |
Lip Swelling |
3.4% |
Myalgia |
3.4% |
Myocardial Infarction |
3.4% |
|
Concomitant |
Hypertension |
31.8% |
Fluid Retention |
16.3% |
Supplementation Therapy |
7.8% |
Drug Use For Unknown Indication |
6.2% |
Blood Pressure Abnormal |
4.7% |
Non-small Cell Lung Cancer Stage Iii |
4.7% |
Product Used For Unknown Indication |
4.7% |
Thyroid Disorder |
3.1% |
Dyspepsia |
2.3% |
Hypersensitivity |
2.3% |
Pain |
2.3% |
Acromegaly |
1.6% |
Asthma |
1.6% |
Atrial Fibrillation |
1.6% |
Blood Pressure |
1.6% |
Blood Pressure High |
1.6% |
Breast Cancer Metastatic |
1.6% |
Diabetes Mellitus |
1.6% |
Electrolyte Substitution Therapy |
1.6% |
Gastrooesophageal Reflux Disease |
1.6% |
|
Burning Sensation |
14.3% |
Rash |
10.7% |
Drug Ineffective |
7.1% |
Post Thrombotic Syndrome |
7.1% |
Somnolence |
7.1% |
Blood Pressure Increased |
3.6% |
Cardiac Disorder |
3.6% |
Cholelithiasis |
3.6% |
Flushing |
3.6% |
Headache |
3.6% |
Hormone Level Abnormal |
3.6% |
Hypertension |
3.6% |
Incorrect Drug Administration Duration |
3.6% |
Injection Site Swelling |
3.6% |
Liquid Product Physical Issue |
3.6% |
Nasal Discomfort |
3.6% |
Nipple Pain |
3.6% |
Oedema Peripheral |
3.6% |
Oral Herpes |
3.6% |
Pain |
3.6% |
|